Pharma channel feed

Ex­clu­sive: A small biotech will bring Roche's An­gel­man drug back to life

Last month
Startups
Deals

Trump phar­ma tar­iffs inch clos­er as ad­min­is­tra­tion con­firms US trade probe

Last month
R&D
Manufacturing

Bris­tol My­ers says Camzyos fails Phase 3 study in ge­net­ic heart con­di­tion

Last month
R&D

CDC vac­cine ad­vi­sors are set to meet this week af­ter two-month de­lay and scruti­ny from Kennedy

Last month
R&D
FDA+

Ab­b­Vie and San­doz agree to drop court spat over Rin­voq patents

Last month
FDA+

San­doz sues Am­gen over nine-year launch de­lay for En­brel biosim­i­lar

Last month
FDA+
Law

What's Pfiz­er's next move af­ter shelv­ing its oral obe­si­ty drug danuglipron?

Last month
Deals

Pri­mate re­searchers cope with un­cer­tain­ty as NIH ap­peals for pay­ment cuts in court 

Last month
R&D
In Focus

Iron­wood to look for al­ter­na­tive paths af­ter FDA asks for an­oth­er Phase 3

Last month
FDA+

Phar­ma tar­iffs to ar­rive 'in the next month or two,' com­merce sec­re­tary says

Last month
Manufacturing

No­var­tis fol­lows Lil­ly and J&J in an­nounc­ing multi­bil­lion-dol­lar US man­u­fac­tur­ing in­vest­ment

Last month
Manufacturing

Vac­cines, obe­si­ty drugs, job cuts: Take­aways from RFK Jr.'s first net­work in­ter­view as HHS chief

Last month
People

Phar­ma tar­iffs: Here’s what a po­ten­tial roll­out could look like

Last month
Manufacturing

Biotech CEOs to Cas­sidy: We're al­ready see­ing the ef­fects of FDA's staff cuts

Last month
FDA+

Drug pric­ing watch­dog ICER of­fers ways to in­crease obe­si­ty drug ac­cess

Last month
FDA+

No­vo Nordisk looks to Brazil to boost GLP-1 man­u­fac­tur­ing with $1B+ bud­get

Last month
Manufacturing

Up­dat­ed: Phar­ma is next in line as Trump says tar­iffs are com­ing 'very short­ly'

Last month
Manufacturing

Phar­ma CEOs warn EU of po­ten­tial ‘ex­o­dus to the US’ as trade war con­tin­ues

Last month
Manufacturing

NIH ap­peals na­tion­wide block on pay­ment cap for re­search grantees

Last month
Law

No­vo Nordisk, HHS clash over ‘ne­go­ti­a­tion-el­i­gi­ble’ drugs in IRA ap­peals fight

Last month
Law

Amid Trump’s re­search cuts, com­mis­sion says US risks los­ing biotech race with­out $15B in­vest­ment

Last month
China

HHS says it may re­vis­it an­ti-obe­si­ty drug poli­cies af­ter drop­ping Biden-era pro­pos­al

Last month
Marketing
Law

Min­neso­ta fed­er­al judge dis­miss­es chal­lenge from Ab­b­Vie, As­traZeneca to state's 340B law

Last month
Law

PureTech re­jects cash ex­it pro­pos­al from Nordic Cap­i­tal, in­vest­ment firm says it won't make an of­fer

Last month
Deals
First page Previous page 567891011 Next page Last page
A service from the Financial Times